The ImmunoVerse™ cover image

Origins of Cancer Immunotherapy, ft. Dr. Steven Rosenberg

The ImmunoVerse™

00:00

FDA approval of TIL for metastatic melanoma

Steven Rosenberg reflects on the long journey to TIL approval, mixed emotions about the delay, and its significance alongside CAR-T approvals.

Play episode from 11:45
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app